13. – 15. September 2022, Venue: Research Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, 1030 Vienna, Austria
Save the date for this excellent networking opportunity and share your work done in the field of proteomics and especially single cell proteomics. In September 2022 we will combine the annal symposium of the Austrian Proteomics and Metabolomics Association (APMA) with a symposium focusing on advancements in single cell proteomics in Vienna/Austria. This allows us to bring specialists from diverse fields together, exchange ideas and start new collaborations. After being held in an online format last year, we plan to have this edition as hybrid event allowing in-person and virtual attendance.
COVID-19: We will have very strict hygiene rules for in person attendees. Admission will only be granted to persons with appropriate vaccination status.
Accommodation: We would like to note that nor APMA, the IMP or we as organizers collaborate with any hotel booking service, especially not with Expo Hotel Services. Please be assured that if you are contacted by them, that they did not receive any information from us and that we are not in any relationship with them.
We want to offer an inspiring environment for scientists interested in newest technological advances and novel strategies not only in MS-based proteomics and metabolomics but also genomics and bioinformatics. We aim to share ideas and discuss future directions in order to encourage outside the box thinking and drive technological innovations.
Topics day 1, 13.09.22
Metabolomics, Lipidomics, Mulitomics
Topics day 2 -3, 14. – 15.09.22
Proteomics & Single Cell Proteomics
Please note that we offer travel grants to students: here
Please note, that our maximum capacity for on-site participants is 150, and we will fill places on the first comes, first serves principle. Participant number and rules (need for vaccination/ PCR test etc.) might change on short notice dependent on regulations in place in Austria at the time of the conference.
|Organisation and Contact|
|Karl Mechtler||Manuel Matzinger|
|IMP – IMBA – GMI||IMP|
|E-Mail: email@example.com||E-Mail: firstname.lastname@example.org|
PI at the Department of Analytical Chemistry focusing on Lipidomics, University of Vienna, Vienna, Austria
Full Professor at the Institute of Chemical Technologies and Analytics of TU Vienna, Austria
Director of Proteomics, Harvard University, Cambridge, MA, US
PhD Student, Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark
Associate Professor, Chemistry and Chemical Biology, Barnett Institute for Chemical & Biological Analysis, Northeastern University, Boston, MA, US
|Ryan T. Kelly|
Associate Professor in the Department of Chemistry and Biochemistry at Brigham Young University, Provo, UT, US
Head of Masspec, FMP Leibniz, Berlin, Germany
Director of Research in Life Sciences Mass Spectrometry for Thermo Scientific and the world-renowned inventor of the Orbitrap mass analyzer technology
Postdoctoral Fellow, Mechtler Lab, Research Institute of Molecular Pathology, Vienna, Austria
Director of the Life Sciences Institute, University of British Columbia, Vancouver, Canada
Principal Scientist, Microchemistry, Proteomics & Lipidomics (MPL) at Genentech
Associate Professor, Cell diversity Lab, Technical University of Denmark, Lyngby, Denmark
Head of Single Cell Proteomics in Cellenion, Lyon, France
Head of Proteomics Biomedicum, Karolinska Institutet, Stockholm, Sweden
Senior biological scientist in Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory,Richland, WA, US
PI at the Department of Medical Biochemistry and Biophysics at the Karolinska Institutet, Stockholm, Sweden